相关实验视频
Updated: Jun 13, 2025

07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
21.6K
用于CRISPR-Cas13a抗菌剂的基基囊体系统,其向的是耐美西林的金黄色葡萄球菌 (Staphylococcus aureus)
Feng-Yu Li1, Xin-Ee Tan1, Yuzuki Shimamori1
1Division of Bacteriology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke city, Tochigi, 329-0498, Japan.
Communications biology
|September 13, 2024
概括
这项研究引入了一种新的系统,使用载有CRISPR-Cas13a的菌体囊来对抗抗生素耐药的细菌,特别是针对金黄色葡萄球菌. 优化的系统提高了生产效率,并确保有针对性的细菌消除.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 多药耐药病原体中抗生素耐药性的升级构成了全球健康的重大威胁.
- 需要有针对性的疗法来对抗抗性细菌感染,如金黄色葡萄球菌.
研究的目的:
- 开发一种创新的基于体的体系统,用于生成载有CRISPR-Cas13a的抗菌体 (AB-体).
- 优化系统,以实现高效生产和针对多药耐药黄金葡萄球菌的向治疗.
主要方法:
- 优化phagemid系统以最大限度地提高AB-capsid的产量和纯度.
- 采用菌体编码的包装部位基因 (terL-terS-rinA-rinB) 实现高包装效率.
- 使用具有terL-terS删除的溶解化宿主,以最大限度地减少野生类型菌体污染.
主要成果:
- 观察到体副本数和AB体产量之间存在正相关性,副本数增加了8.65倍,AB体产量增加了2.54倍.
- 带有terL-terS-rinA-rinB基因的法基因表现出高的包装效率.
- 在具有terL-terS删除的宿主中产生AB囊体减少了野生类型菌体的污染,对产量的影响最小.
结论:
- 开发的基于体的体系统是生产特定序列的杀菌剂的有希望的方法.
- 该系统提供了一种有效和有针对性的策略,用于对抗抗生素耐药性病原体.
相关概念视频
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
CRISPR
49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K

